These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 412105

  • 1. Toxicology of anticancer drugs.
    Guarino AM.
    Natl Cancer Inst Monogr; 1977 Mar; (45):49-55. PubMed ID: 412105
    [No Abstract] [Full Text] [Related]

  • 2. The clinical toxicity of anticancer drugs and its prediction.
    Creaven PJ, Mihich E.
    Semin Oncol; 1977 Jun; 4(2):147-63. PubMed ID: 406677
    [No Abstract] [Full Text] [Related]

  • 3. Preclinical toxicology of anticancer agents.
    Schein PS.
    Cancer Res; 1977 Jun; 37(6):1934-7. PubMed ID: 404039
    [No Abstract] [Full Text] [Related]

  • 4. Preclinical toxicology protocols of the Laboratory of Toxicology.
    Prieur DJ, Young DM, Davis RD, Cooney DA, Guarino AM.
    Natl Cancer Inst Monogr; 1977 Mar; (45):159-77. PubMed ID: 412104
    [No Abstract] [Full Text] [Related]

  • 5. Toxicology and pharmacology of the nitrosoureas.
    Oliverio VT.
    Cancer Chemother Rep 3; 1973 May; 4(3):13-20. PubMed ID: 4201308
    [No Abstract] [Full Text] [Related]

  • 6. Preclinical study of antitumor compounds.
    Syrkin AB.
    Natl Cancer Inst Monogr; 1977 Mar; (45):255-9. PubMed ID: 927492
    [No Abstract] [Full Text] [Related]

  • 7. Preclinical toxicology studies with ICRF-159 (NSC-129943)--a new antineoplastic drug.
    Gralla EJ, Coleman GL, Jonas AM.
    Cancer Chemother Rep 3; 1974 Sep; 5(1):1-7. PubMed ID: 4213305
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.
    Goldsmith MA, Slavik M, Carter SK.
    Cancer Res; 1975 May; 35(5):1354-64. PubMed ID: 804350
    [Abstract] [Full Text] [Related]

  • 9. Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome.
    Mirsalis JC, Schindler-Horvat J, Hill JR, Green CE, Mitoma C, Tomaszewski JE, Tyson CA, Donohue SJ.
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):193-201. PubMed ID: 12655436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical development of anticancer agents--a National Cancer Institute perspective.
    Marsoni S, Wittes R.
    Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
    [No Abstract] [Full Text] [Related]

  • 13. Preclinical toxicology of alpha-2'-deoxythioguanosine (NSC-71851).
    Henry MC, DiDomenico E.
    Cancer Chemother Rep 3; 1974 Sep; 5(1):9-14. PubMed ID: 4213304
    [No Abstract] [Full Text] [Related]

  • 14. CCNU (NSC-79037): preclinical toxicologic evaluation of a single intravenous infusion in dogs and monkeys.
    Schaeppi U, Fleischman RW, Phelan RS, Ethier MF, Luthra YK.
    Cancer Chemother Rep 3; 1974 Sep; 5(1):53-64. PubMed ID: 4213020
    [No Abstract] [Full Text] [Related]

  • 15. 1,6-Di-O-methanesulphonyl-2,3-4,5-dianhydro-L-iditol, a new potential antitumour agent. Biological investigations.
    Csányi E, Halász M.
    Arzneimittelforschung; 1973 Jul; 23(7):961-7. PubMed ID: 4356189
    [No Abstract] [Full Text] [Related]

  • 16. Phase I trials of single agents in adult solid tumours: preclinical and clinical aspects.
    Dodion P, Kenis Y, Staquet M.
    Drugs Exp Clin Res; 1986 Jul; 12(1-3):23-30. PubMed ID: 3732050
    [Abstract] [Full Text] [Related]

  • 17. Animal toxicology for early clinical trials with anticancer agents.
    Rozencweig M, Von Hoff DD, Staquet MJ, Schein PS, Penta JS, Goldin A, Muggia FM, Freireich EJ, DeVita VT.
    Cancer Clin Trials; 1981 Jul; 4(1):21-8. PubMed ID: 6783332
    [Abstract] [Full Text] [Related]

  • 18. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA, Konovalova AL, Korol'chuk VP.
    Vestn Akad Med Nauk SSSR; 1979 Jul; (2):68-80. PubMed ID: 105504
    [No Abstract] [Full Text] [Related]

  • 19. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
    Trinus FP, Sologub PY, Protsenko LD, Tarnavskaya MI, Nikolaeva SV, Danilenko VS, Sharykina NI, Kolodyazhny VI, Zaikina RG, Goncharenko GV, Kopel'nik MA, Andrianova SM.
    Vopr Onkol; 1979 Jul; 25(9):53-8. PubMed ID: 90429
    [Abstract] [Full Text] [Related]

  • 20. ICRF-187 in clinical oncology.
    Poster DS, Penta JS, Bruno S, Macdonald JS.
    Cancer Clin Trials; 1981 Jul; 4(2):143-6. PubMed ID: 6788388
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.